Ondansetron Orally Disintegrating Tablets

Related by string. * ondansetron : Ondansetron Injection USP . ondansetron Oral Spray . Ondansetron Hydrochloride / orally : orally ingested . orally absorbed . orally committed / disintegrated . disintegrating : orally disintegrating tablet . fuselage disintegrated . orally disintegrating tablets / TABLET . TABLETS . tableting : Extended Release Tablets . Galaxy Tab tablet * *

Related by context. Frequent words. (Click for all words.) 72 Receives Orphan Drug Designation 71 Meets Primary Endpoint 70 FDA Accepts 69 Initiates Phase II 69 FDA Clears 69 Generic Version 69 Presents Positive 69 Commences Phase 68 gets USFDA nod 68 Single Dose 68 Announces FDA Clearance 68 Drug Candidate 68 Guides FY# Quick Facts 68 Completes Enrollment 68 Arthritis Drug 67 Osteoporosis Drug 67 Signs License Agreement 67 Declares Dividend Quick Facts 66 Phase III Clinical Trial 66 Purchase CIALIS Need 66 Initiate Phase 66 Inhalation Aerosol 66 Milestone Payment 66 Drug Shows Promise 65 Receives FDA Clearance 65 Guides Q4 65 Guides Q2 65 Lifts FY# EPS 65 Initiates Phase 65 Shareholders Approve Acquisition 65 Inhaled Insulin 65 Develop Novel 65 Clinical Trial Results 65 Enrolls First 65 Preclinical Data 64 Cholesterol Drug 64 Vytorin combines 64 Announces Organizational Changes 64 Flagship Product 64 Patient Enrollment 64 Pivotal Phase 64 Completes Tender Offer 64 Provides Shareholder 64 Guides Q1 64 Inc Therapeutic Competitors 64 Q2 Loss Widens 64 Forecast Quick Facts 64 Q1 Loss Narrows 64 Blood Thinner 63 #mg #mg [002] 63 Q1 Profit Surges 63 Q4 Loss Narrows 63 Oral Solution 63 Achieves Milestone 63 Announces Initiation 63 Anemia Drugs 63 Announces Immediate Availability 63 Q2 Profit Surges 63 #-# Full Text 63 REUTERS Claro Cortes 63 Strengthens Leadership 63 Q3 Loss Widens 63 Q1 Loss Widens 63 Q2 Loss Narrows 63 Q3 Loss Narrows 63 Calls Purchased 63 Expands Portfolio 62 Explore Strategic Alternatives 62 Pivotal Phase III 62 Clarithromycin 62 FDA Approves 62 Am J Obstet 62 Second Quarter Profit Rises 62 Guides FY# 62 Puts Purchased 62 Sapacitabine 62 Expands Capabilities 62 Secures Financing 62 Lowers Guidance 62 Fast Track Status 62 RELEASES ITS QUARTERLY NUMBERS 62 Marcus Gronholm BP 62 Q3 Profit Surges 62 Joint Surg Br 62 Q4 Loss Widens 62 Extended Release 62 HOW LONG WAS 62 INVESTORS BID UP 62 Net Loss Narrows 62 Child Adolesc Psychiatry 62 Acetate Rectal Suppositories 62 CHEAP ONLINE PHARMACY LOW 62 By Neil Osterweil 62 Jumps Higher 62 Weight Loss Drug 62 PHARMACEUTICALS 62 Transcept Pharmaceuticals 62 SHARES CREEPING HIGHER UP 62 #.#X ABOVE AVERAGE VOLUME 61 Above Consensus 61 Release Tablets

Back to home page